Influence of Aortic Valve Stenosis and Wall Shear Stress on Platelets Function

Paweł Bańka1, Maciej Wybraniec1, Tomasz Bochenek1

  • 1First Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia, 40-635 Katowice, Poland.

PubMed

Insights

Aortic valve stenosis (AS) causes high shear stress, leading to bleeding disorders and platelet activation. This review explores AS

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Pathophysiology

Background:

  • Aortic valve stenosis (AS) is a prevalent condition in the elderly, characterized by progressive aortic valve leaflet degeneration, fibrosis, and calcification.
  • The resulting turbulent blood flow and elevated shear stress significantly impact cardiovascular health and hemostasis.
  • Understanding the pathogenesis of AS is crucial for developing effective therapeutic strategies.

Purpose of the Study:

  • To review current knowledge on high shear stress-induced hemostatic disorders in the context of AS.
  • To explore the influence of AS on platelet function and activation.
  • To discuss the implications for antiplatelet therapy in patients with AS.

Main Methods:

  • Literature review of existing research on AS, shear stress, and hemostasis.
  • Analysis of the mechanisms linking turbulent blood flow to von Willebrand factor degradation and platelet activation.
  • Synthesis of information on the role of platelets and their mediators in AS pathogenesis.

Main Results:

  • Elevated shear stress in AS can degrade von Willebrand factor, potentially causing mucosal bleeding.
  • High shear stress also promotes thrombin release and platelet activation, even in acquired von Willebrand syndrome.
  • Turbulent flow activates endothelium and aortic valve surfaces, promoting platelet adhesion and mediator release, including pro-osteogenic factors.

Conclusions:

  • AS-induced high shear stress triggers complex hemostatic disorders involving coagulation, fibrinolysis, and platelet dysfunction.
  • Platelet activation and mediator release play a significant role in the progression of AS.
  • Further research into these mechanisms is essential for optimizing antiplatelet therapy in AS patients.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
15
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.5K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
538
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
13
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12